ريتاتروتايد: المادة اللي هتغير العالم في 2026.. جهز نفسك!

Everyone's talking about Ozempic and Mongaro right now, and we consider them the pinnacle of medical advancement. But the truth is, the upcoming Retatrutide is a substance that will change the world in 2026 and make these medications seem obsolete. In this video, I'm going to talk to you about the very near future. We're not just talking about a slightly stronger weight-loss drug; we're talking about a substance that produces results similar to gastric sleeve surgery, but without the procedure. For the first time, this drug combines three hormones to force your body to burn fat in a way we've never seen before. We'll discuss: 1- Why does this drug help you lose more than 24% of your weight in less than a year? And what's the secret behind the "Triple G"? 2- How did it completely eliminate liver fat in most cases? And does this mean the end of fatty liver disease? 3- Retatrotide or Mongaro (Tirzepatide)? Which one is the real king and why? 4- Side effects and risks of using it 5- When will it be available on the market? And will it really replace other medications? This video is packed with information, all from the latest research published in 2024 and 2025, so you get the full picture, not just headlines. ⚠️ Important note: This information is for awareness purposes only. Retatrotide is still in the final stages of clinical trials (Phase 3) and is not yet officially available for sale. If you're interested in your health and want to understand how your body works, don't forget to like and subscribe to the channel. If you have any questions, leave them in the comments. For contact and inquiries about follow-up, training programs, and nutrition: https://beacons.ai/mechanicsofbodybui... Social Media:   / coach.khalaf     / coach.khalaf   Discord Server:   / discord   Sources: https://pace-cme.org/news/results-of-... https://synapse.patsnap.com/article/w... https://pmc.ncbi.nlm.nih .gov/articles/PMC12190491/ https://pmc.ncbi.nlm.nih.gov/articles... https://www.researchgate.net/profile/... y-and-type-2-diabetes https://thecarepharmacy.com/retatruti... https://pmc.ncbi.nlm.nih.gov/articles... https://pmc.ncbi.nlm.nih.gov/articles... https://pmc.ncbi.nlm.nih.gov/articles... https://www.prnewswire.c om/news-releases/lillys-phase-2-retatrutide-results-published-in-the-new-england-journal-of-medicine-show-the-investigational-molecule-achieved-up-to-17-5-mean-weight-reduction-at-24-weeks-in-adults-with-obesity-and-overweight-301863690.html https://pubmed.ncbi.nlm.nih.gov/373663 15/ https://www.tctmd.com/news/dramatic-w... https://firstwordpharma.com/story/576... https://www.adameetingnews.org/phase-... https://www.droracle.ai /articles/412939/what-is-the-fda-approval-status-of-retatrutide https://www.vcuhealth.org/news/retatr... https://thelimbic.com/endocrinology/t... https://www.medrxiv.org/content/ 10.1101/2025.07.05.25330933v1.full https://www.clinicaltrialsarena.com/a... https://www.droracle.ai/articles/4761... https://www.researchgate .net/publication/393414339_Inotropic_effects_of_retatrutide_in_isolated_human_atrial_preparations https://www.springermedizin.de/inotro... https://academic.oup.com/ndt/advance-... https://www.researchgate.net/publicat... https://www.researchgate.net/publicat... https://pubmed.ncbi.nlm.nih.gov/41160... https://nowpatient.com/blog/what-are-... https://www.biophar madive.com/news/eli-lilly-retatrutide-obesity-drug-results/653974/ https://pubmed.ncbi.nlm.nih.gov/41090... https://www.clinicaltrials.gov/study/... https://clinicaltrials.gov/study/NCT0... https://ctv.veeva.com/stud y/a-study-of-retatrutide-ly3437943-compared-to-tirzepatide-ly3298176-in-adults-who-have-obesity https://clinicaltrials.gov/study/NCT0... https://clinicaltrials.gov/study/NCT0... https://clinicaltrials.gov/study/NCT0...